Colgate-Palmolive (NYSE:CL) Shares Bought by Grimes & Company Inc.

Grimes & Company Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 3.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 12,503 shares of the company’s stock after acquiring an additional 410 shares during the quarter. Grimes & Company Inc.’s holdings in Colgate-Palmolive were worth $1,137,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Peak Financial Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $602,000. Carrera Capital Advisors lifted its holdings in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after buying an additional 7,353 shares during the period. Fiduciary Alliance LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $4,066,000. Finally, Vontobel Holding Ltd. lifted its holdings in shares of Colgate-Palmolive by 224.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after buying an additional 550,750 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Barclays decreased their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Finally, Stifel Nicolaus reduced their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $101.11.

View Our Latest Analysis on CL

Colgate-Palmolive Price Performance

CL stock opened at $87.88 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business has a 50 day simple moving average of $91.81 and a 200-day simple moving average of $97.44. The firm has a market capitalization of $71.79 billion, a PE ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $80.03 and a 1 year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.